Filing Details

Accession Number:
0001209191-22-024917
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-04-20 16:05:37
Reporting Period:
2022-04-19
Accepted Time:
2022-04-20 16:05:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1693011 Inozyme Pharma Inc. INZY () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1579247 Axel Bolte C/O Inozyme Pharma, Inc.
321 Summer Street Suite 400
Boston MA 02210
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-04-19 67,750 $3.69 258,575 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct